Comparison of multiplex immunoassay platforms

Clinical Chemistry

Volumn 56, Issue 2, 2010, Pages 314-318

  Fu, Qin ^a   Zhu, Jie ^a   Van Eyk, Jennifer E ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Johns Hopkins University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; IMMUNOASSAY; MALE; MEDICAL INSTRUMENTATION; MUTIPLEX IMMUNOASSAY PLATFORM; NORMAL HUMAN;

BIOLOGICAL MARKERS; BLOOD PROTEINS; CYTOKINES; HUMANS; IMMUNOASSAY; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS;

EID: 75749157812     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2009.135087     Document Type: Article

References (15)

1. Banks RE, Dunn MJ, Hochstrasser DF, Sanchez JC, Blackstock W, Pappin DJ, et al. Proteomics: new perspectives, new biomedical opportunities. Lancet 2000;356:1749 -56.
2. Patterson SD. Proteomics: beginning to realize its promise? Arthritis Rheum 2004;50:3741-4.
3. Kingsmore SF. Multiplexed protein measurement: technologies and applications of protein and antibody arrays. Nat Rev Drug Discov 2006;5:310-20.
4. Fu Q, Van Eyk JE. Proteomics and heart disease: identifying biomarkers of clinical utility. Expert Rev Proteomics 2006;3:237-49.
5. Rifai N, Gillette MA, Carr SA. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol 2006;24:971-83.
6. Zolg JW, Langen H. How industry is approaching the search for new diagnostic markers and biomarkers. Mol Cell Proteomics 2004;3:345-54.
7. Rifai N, Gerszten RE. Biomarker discovery and validation. Clin Chem 2006;52:1635-7.
8. Price C, Newman D. Principles and practices of immunoassays. New York: Stockton Press; 1997. 750 p.
9. Sachdeva N, Asthana D. Cytokine quantitation: technologies and applications. Front Biosci 2007;12:4682-95.
10. Prabhakar U, Eirikis E, Miller BE, Davis HM. Multiplexed cytokine sandwich immunoassays: clinical applications. Methods Mol Med 2005;114:223-32.
11. Utz PJ. Multiplexed assays for identification of biomarkers and surrogate markers in systemic lupus erythematosus. Lupus 2004;13:304-11.
12. Schweitzer B, Roberts S, Grimwade B, Shao W, Wang M, Fu Q, et al. Multiplexed protein profiling on microarrays by rolling-circle amplification. Nat Biotechnol 2002;20:359-65.
13. Kingsmore SF, Kennedy N, Halliday HL, Van Velkinburgh JC, Zhong S, Gabriel V, et al. Identification of diagnostic biomarkers for infection in premature neonates. Mol Cell Proteomics 2008;7:1863-75.
14. Sabatine MS, Morrow DA, de Lemos JA, Gibson CM, Murphy SA, Rifai N, et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 2002;105:1760-3.
15. Ling MM, Ricks C, Lea P. Multiplexing molecular diagnostics and immunoassays using emerging microarray technologies. Expert Rev Mol Diagn 2007;7:87-98.